950130 — Access Bio Income Statement
0.000.00%
Last trade - 00:00- KR₩441bn
- KR₩153bn
- $267.08m
- 43
- 81
- 12
- 39
Annual income statement for Access Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 36.9 | 103 | 441 | 800 | 267 |
| Cost of Revenue | |||||
| Gross Profit | 8.07 | 76.9 | 346 | 635 | 130 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 51.3 | 47.5 | 214 | 437 | 249 |
| Operating Profit | -14.3 | 55.7 | 227 | 363 | 18 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -18.5 | 52.9 | 224 | 359 | -4.5 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -17.7 | 40.5 | 166 | 271 | -4.06 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -15.1 | 40.9 | 166 | 268 | -2.43 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -15.1 | 41.1 | 167 | 270 | -2.43 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.357 | 1.24 | 4.48 | 7.13 | -0.101 |
| Dividends per Share |